Noven Pharmaceuticals v Novartis Pharmaceuticals

BVLaw
Full Text of Court Cases
November 9, 2018

Access the Full Article

This article and its downloads are available with a subscription to any of these products:
Already a subscriber?  Login
This article is also available for purchase. (2,928 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
2834 Pharmaceutical Preparations
325412 Pharmaceutical Preparation Manufacturing
discovery
discovery, work-product doctrine, relevant, valuation report, attorney-client privilege
Noven Pharmaceuticals v Novartis Pharmaceuticals
2018 N.Y. Mis. LEXIS 5133
US
State Court
New York
Supreme Court
N/A (plaintiff); N/A (defendant)
Schecter

Summary

In breach of contract action, court finds defendant’s valuation report is discoverable; report is relevant to an issue in dispute and not protected by attorney-client privilege or work-product doctrine where valuation was not done solely in anticipation of litigation but had mixed purpose.
Noven Pharmaceuticals v Novartis Pharmaceuticals
PDF, Size: 396 KB

See Also

Court Finds Defendant’s Valuation Had ‘Mixed Purpose’ and Orders Disclosure

Court Case Digests
November 9, 2018

In breach of contract action, court finds defendant’s valuation report is discoverable; report is relevant to an issue in dispute and not protected by attorney-client privilege or work-product doctrine where valuation was not done solely in anticipation of litigation but had mixed purpose.